Intellectus Partners’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,000
Closed -$92K 273
2022
Q3
$92K Hold
33,000
0.03% 245
2022
Q2
$41K Buy
+33,000
New +$55.3K 0.01% 242
2022
Q1
Sell
-33,000
Closed -$221K 279
2021
Q4
$221K Buy
+33,000
New +$320K 0.06% 248

Intellectus Partners's ZY Position: Q4 2022 in Review

Intellectus Partners sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 33,000 shares — an estimated $92K sold.

Intellectus Partners first reported a position in ZY in Q4 2021 and held it in 3 quarters. The position peaked at $221K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Intellectus Partners reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Intellectus Partners sold 33,000 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $92K.
  • Intellectus Partners first reported a position in Zymergen Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Intellectus Partners's Zymergen Inc. Common Stock position peaked at $221K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Intellectus Partners's 13F filing for Q4 2022, filed 2 Feb 2023.